Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With Metformin Compared With Metformin Plus Sitagliptin, Metformin Plus Glimepiride, and Metformin Plus Placebo in Subjects With Type 2 Diabetes Mellitus
Brief Summary: The purpose of this study is to determine if albiglutide is safe and effective in the treatment of type 2 diabetes.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Canagliflozin (JNJ-28431754) 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin (JNJ-28431754) 100 mg | Arm Label: Canagliflozin (JNJ-28431754) 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin (JNJ-28431754) 300 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Canagliflozin (JNJ-28431754) 100 mg; Assigned to Arm(s): Canagliflozin (JNJ-28431754) 100 mg | Intervention Type: DRUG; Name: Canagliflozin (JNJ-28431754) 300 mg; Assigned to Arm(s): Canagliflozin (JNJ-28431754) 300 mg
B: Arm Label: Canagliflozin 100 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin | Arm Label: Canagliflozin 300 mg; Type: EXPERIMENTAL; Interventions: Drug: Canagliflozin | Arm Label: Placebo/Sitagliptin; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: Sitagliptin | Intervention Type: DRUG; Name: Canagliflozin; Assigned to Arm(s): Canagliflozin 100 mg, Canagliflozin 300 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo/Sitagliptin | Intervention Type: DRUG; Name: Sitagliptin; Assigned to Arm(s): Placebo/Sitagliptin
C: Arm Label: albiglutide + metformin; Type: EXPERIMENTAL; Interventions: Biological: albiglutide, Drug: metformin, Drug: placebo sitagliptin, Drug: placebo glimepiride | Arm Label: sitagliptin + metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: sitagliptin, Drug: metformin, Biological: placebo albiglutide, Drug: placebo glimepiride | Arm Label: glimepiride + metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: glimepiride, Drug: metformin, Biological: placebo albiglutide, Drug: placebo sitagliptin | Arm Label: metformin + placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: metformin, Biological: placebo albiglutide, Drug: placebo sitagliptin, Drug: placebo glimepiride | Intervention Type: BIOLOGICAL; Name: albiglutide; Assigned to Arm(s): albiglutide + metformin | Intervention Type: DRUG; Name: sitagliptin; Assigned to Arm(s): sitagliptin + metformin | Intervention Type: DRUG; Name: glimepiride; Assigned to Arm(s): glimepiride + metformin | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): albiglutide + metformin, glimepiride + metformin, metformin + placebo, sitagliptin + metformin | Intervention Type: BIOLOGICAL; Name: placebo albiglutide; Assigned to Arm(s): glimepiride + metformin, metformin + placebo, sitagliptin + metformin | Intervention Type: DRUG; Name: placebo sitagliptin; Assigned to Arm(s): albiglutide + metformin, glimepiride + metformin, metformin + placebo | Intervention Type: DRUG; Name: placebo glimepiride; Assigned to Arm(s): albiglutide + metformin, metformin + placebo, sitagliptin + metformin
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: add-on pioglitazone | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: add-on sulphonylurea | Intervention Type: DRUG; Name: add-on pioglitazone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: add-on sulphonylurea; Assigned to Arm(s): 2

Answer: C